DARPA research program support services
Ended Awarded Last action
- Contract number
- HR001126FE020
- Awardee
-
The General Hospital Corporation UEI FLJ7DQKLL226
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $75,484
Award facts
- Contract value 2% obligated
-
- $75,484.00 Current, with exercised options
- $3,063,860.04 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02114, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $75,484 |
About this award
The Defense Advanced Research Projects Agency (DARPA) awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at approximately $3.06 million to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for DARPA Research Program Support Services. The contract is performance-based in Boston, Massachusetts, with an ultimate completion date of May 27, 2027, and was awarded on December 29, 2025. This award represents a task order issued under MGH's existing $25 million DARPA BPA vehicle (effective August 21, 2024 through August 20, 2027) focused on Commercial Accelerators Support Services. No small business set-aside was used for this procurement. MGH's Research Management Division will deliver specialized research and commercialization services leveraging the institution's extensive biomedical research infrastructure and translational capabilities across multiple scientific domains.
Under this task order, MGH will provide commercial accelerator support services encompassing clinical evaluations of emerging technologies, expert convening, clinical trial protocol development, intellectual property validation, operational capability assessments, strategic business support, market analysis, go-to-market strategy development, and company mentoring. MGH, a premier nonprofit academic medical center and Harvard Medical School teaching hospital, brings substantial federal research credentials and serves as both prime and sub-awardee across numerous NIH grant programs in oncology, neuroscience, cardiovascular research, infectious diseases, and precision medicine. The organization engages subcontractors such as Bridgewood Research Solutions LLC to deliver comprehensive clinical and commercial services. This BPA structure reflects DARPA's strategic reliance on MGH's research capabilities to advance innovative solutions with applications to national defense and scientific innovation.
Quick answers
Who was awarded contract HR001126FE020?
HR001126FE020 was awarded to The General Hospital Corporation by Defense Advanced Research Projects Agency (Department of Defense) on December 29, 2025.
How much is contract HR001126FE020 worth?
The government has obligated $75,484 on HR001126FE020. Its potential value, with all options, is $3,063,860.
Is contract HR001126FE020 an order under another contract?
Yes. HR001126FE020 is a BPA call under HR001124A0003, a blanket purchase agreement.
Was contract HR001126FE020 competed?
The extent of competition for HR001126FE020 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award